Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Clinical Research Coordinator
Lovelace Respiratory Research Institute - Albuquerque, NM
Hematology Oncology Consultant, Hematology - Louisiana North Job
Celgene Corporation - Louisiana, LA, US
Patient Support Specialist Job
Celgene Corporation - Berkeley Heights, NJ, US
Director, IT Global Operation Services, End-User Informatics Job
Celgene Corporation - Summit, NJ, US
Clinical Trials Site Director
Lovelace Respiratory Research Institute - Albuquerque, NM

More Jobs >>

Events

Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia
Just Released: New Trends in Preventive and Therapeutic Vaccine
Enforcement, Litigation and Compliance Conference
Dec. 6-7 — Washington, DC
New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA

More Events >>

Related Tags >> flu vaccine Vaccine influenza CDC

Flu Shot News

Most Popular Flu Shot Story

Manufacturers get an early start on flu vax shipments

August 5, 2010 — 8:03am ET | By John Carroll

Vaccine manufacturers have begun to deliver huge shipments of the new seasonal flu vaccine ahead of schedule. This year's shot protects against two strains of seasonal flu as well as H1N1, doing away Read more...

Latest Headlines

British PM: We will learn from the current flu crisis
January 7, 2011
Manufacturers get an early start on flu vax shipments
August 5, 2010
CDC recommends flu jab for children up to 18
February 28, 2008

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK